Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
Front Vet Sci ; 10: 1229756, 2023.
Article in English | MEDLINE | ID: mdl-37645673

ABSTRACT

Positive clinical outcomes of a group of surviving puppies from a litter affected by parvoviral myocarditis are detailed in this case report. Past reports focus on the negative outcomes of littermates of puppies who have died of parvoviral myocarditis. In this case, two puppies in a shelter setting, from a litter exposed to parvovirus, died suddenly with parvoviral myocarditis diagnosed at necropsy. The other seven puppies were screened for cardiac health with echocardiogram, electrocardiogram, and cardiac troponin I prior to adoption. All seven puppies had normal echocardiograms, electrocardiograms, and normal initial and recheck cardiac troponin I results. At recheck 2 years after the initial round of testing, two of the puppies were screened and continue to have normal cardiac diagnostics. All seven dogs are alive and thriving at 5 years old in homes with adopters who were given a complete medical history on the dogs prior to adoption. In summary, the outcomes for puppies in litters affected by parvoviral myocarditis are variable but they do not have to be grave. The use of cardiac diagnostics including echocardiogram, electrocardiogram and cardiac troponin I may serve as a prognostic basis for assessing the potential outcomes for the surviving puppies in affected litters.

2.
PLoS One ; 18(1): e0280186, 2023.
Article in English | MEDLINE | ID: mdl-36662900

ABSTRACT

Canine distemper virus remains an important source of morbidity and mortality in animal shelters. RT-PCR is commonly used to aid diagnosis and has been used to monitor dogs testing positive over time to gauge the end of infectious potential. Many dogs excrete viral RNA for prolonged periods which has complicated disease management. The goal of this retrospective study was to describe the duration and characteristics of viral RNA excretion in shelter dogs with naturally occurring CDV and investigate the relationship between that viral RNA excretion and infectious potential using virus isolation data. Records from 98 different humane organizations with suspect CDV were reviewed. A total of 5,920 dogs were tested with 1,393; 4,452; and 75 found to be positive, negative, or suspect on RT-PCR respectively. The median duration of a positive test was 34 days (n = 325), and 25% (82/325) of the dogs still excreting viral RNA after 62 days of monitoring. Virus isolation was performed in six dogs who were RT-PCR positive for > 60 days. Infectious virus was isolated only within the first two weeks of monitoring at or around the peak viral RNA excretion (as detected by the lowest cycle threshold) reported for each dog. Our findings suggest that peak viral RNA excretion and the days surrounding it might be used as a functional marker to gauge the end of infectious risk. Clarifying the earliest point in time when dogs testing positive for canine distemper by RT-PCR can be considered non-contagious will improve welfare and lifesaving potential of shelters by enabling recovered dogs to be cleared more quickly for live release outcomes.


Subject(s)
Distemper Virus, Canine , Distemper , Dogs , Animals , Distemper Virus, Canine/genetics , Retrospective Studies , RNA, Viral/genetics
3.
Front Vet Sci ; 8: 745345, 2021.
Article in English | MEDLINE | ID: mdl-34957275

ABSTRACT

Understanding social, economic, and structural barriers to accessing pet care services is important for improving the health and welfare of companion animals in underserved communities in the U.S. From May 2018-December 2019, six questions from the validated One Health Community Assessment were used to measure perceptions of access to pet care in two urban and two rural zip codes. One urban and one rural community received services from a pet support outreach program (Pets for Life), while the other served as a comparison community. After propensity score matching was performed to eliminate demographic bias in the sample (Urban = 512 participants, Rural = 234 participants), Generalized Estimating Equations were employed to compare the six measures of access to pet care between the intervention and comparison communities. The urban community with the Pets for Life intervention was associated with a higher overall measure of access to pet care compared to the urban site that did not have the Pets for Life intervention. When assessing each of the six measures of access to care, the urban community with the Pets for Life intervention was associated with higher access to affordable pet care options and higher access to pet care service providers who offer payment options than the community without the Pets for Life intervention. Further analyses with a subset of Pets for Life clients comparing pre-intervention and post-intervention survey responses revealed statistically significant positive trends in perceptions of two of the six measures of access to pet care. This study provides evidence that community-based animal welfare programming has the potential to increase perceptions of access to pet support services.

4.
J Virol ; 92(16)2018 08 15.
Article in English | MEDLINE | ID: mdl-29875234

ABSTRACT

Avian-origin H3N2 canine influenza virus (CIV) transferred to dogs in Asia around 2005, becoming enzootic throughout China and South Korea before reaching the United States in early 2015. To understand the posttransfer evolution and epidemiology of this virus, particularly the cause of recent and ongoing increases in incidence in the United States, we performed an integrated analysis of whole-genome sequence data from 64 newly sequenced viruses and comprehensive surveillance data. This revealed that the circulation of H3N2 CIV within the United States is typified by recurrent epidemic burst-fade-out dynamics driven by multiple introductions of virus from Asia. Although all major viral lineages displayed similar rates of genomic sequence evolution, H3N2 CIV consistently exhibited proportionally more nonsynonymous substitutions per site than those in avian reservoir viruses, which is indicative of a large-scale change in selection pressures. Despite these genotypic differences, we found no evidence of adaptive evolution or increased viral transmission, with epidemiological models indicating a basic reproductive number, R0, of between 1 and 1.5 across nearly all U.S. outbreaks, consistent with maintained but heterogeneous circulation. We propose that CIV's mode of viral circulation may have resulted in evolutionary cul-de-sacs, in which there is little opportunity for the selection of the more transmissible H3N2 CIV phenotypes necessary to enable circulation through a general dog population characterized by widespread contact heterogeneity. CIV must therefore rely on metapopulations of high host density (such as animal shelters and kennels) within the greater dog population and reintroduction from other populations or face complete epidemic extinction.IMPORTANCE The relatively recent appearance of influenza A virus (IAV) epidemics in dogs expands our understanding of IAV host range and ecology, providing useful and relevant models for understanding critical factors involved in viral emergence. Here we integrate viral whole-genome sequence analysis and comprehensive surveillance data to examine the evolution of the emerging avian-origin H3N2 canine influenza virus (CIV), particularly the factors driving ongoing circulation and recent increases in incidence of the virus within the United States. Our results provide a detailed understanding of how H3N2 CIV achieves sustained circulation within the United States despite widespread host contact heterogeneity and recurrent epidemic fade-out. Moreover, our findings suggest that the types and intensities of selection pressures an emerging virus experiences are highly dependent on host population structure and ecology and may inhibit an emerging virus from acquiring sustained epidemic or pandemic circulation.


Subject(s)
Dog Diseases/epidemiology , Dog Diseases/virology , Epidemics , Influenza A Virus, H3N2 Subtype/isolation & purification , Orthomyxoviridae Infections/veterinary , Animals , Basic Reproduction Number , Disease Transmission, Infectious , Dogs , Molecular Epidemiology , Orthomyxoviridae Infections/epidemiology , Orthomyxoviridae Infections/virology , Phylogeny , Selection, Genetic , Sequence Analysis, DNA , United States/epidemiology , Whole Genome Sequencing
5.
Virology ; 518: 385-397, 2018 05.
Article in English | MEDLINE | ID: mdl-29605685

ABSTRACT

Feline herpes virus type 1 (FHV-1) is widely considered to be the leading cause of ocular disease in cats and has been implicated in upper respiratory tract infections. Little, however is known about interstrain phylogenetic relationships, and details of the genomic structure. For the present study, twenty-six FHV-1 isolates from different cats in animal shelters were collected from eight separate locations in the USA, and the genomes sequenced. Genomic characterization of these isolates includied short sequence repeat (SSR) detection, with fewer SSRs detected, compared to herpes simplex viruses type 1 and 2. For phylogenetic and recombination analysis, 27 previously sequenced isolates of FHV-1 were combined with the 26 strains sequenced for the present study. The overall genomic interstrain genetic distance between all available isolates was 0.093%. Phylogenetic analysis identified four main FHV-1 clades primarily corresponding to geographical collection site. Recombination analysis suggested that interclade recombination has occurred.


Subject(s)
Genetic Variation , Genome, Viral , Phylogeny , Recombination, Genetic , Varicellovirus/classification , Varicellovirus/genetics , Animals , Cat Diseases/virology , Cats , Global Health , Herpesviridae Infections/veterinary , Sequence Analysis, DNA , Varicellovirus/isolation & purification
7.
Emerg Infect Dis ; 23(12)2017 12.
Article in English | MEDLINE | ID: mdl-29148400
9.
Emerg Infect Dis ; 23(12): 1950-1957, 2017 12.
Article in English | MEDLINE | ID: mdl-28858604

ABSTRACT

A canine influenza A(H3N2) virus emerged in the United States in February-March 2015, causing respiratory disease in dogs. The virus had previously been circulating among dogs in Asia, where it originated through the transfer of an avian-origin influenza virus around 2005 and continues to circulate. Sequence analysis suggests the US outbreak was initiated by a single introduction, in Chicago, of an H3N2 canine influenza virus circulating among dogs in South Korea in 2015. Despite local control measures, the virus has continued circulating among dogs in and around Chicago and has spread to several other areas of the country, particularly Georgia and North Carolina, although these secondary outbreaks appear to have ended within a few months. Some genetic variation has accumulated among the US viruses, with the appearance of regional-temporal lineages. The potential for interspecies transmission and zoonotic events involving this newly emerged influenza A virus is currently unknown.


Subject(s)
Disease Outbreaks , Dog Diseases/epidemiology , Genome, Viral , Influenza A Virus, H3N2 Subtype/genetics , Orthomyxoviridae Infections/epidemiology , Orthomyxoviridae Infections/veterinary , Animals , Chicago/epidemiology , Dog Diseases/transmission , Dog Diseases/virology , Dogs , Georgia/epidemiology , High-Throughput Nucleotide Sequencing , Housing, Animal , Humans , Incidence , Influenza A Virus, H3N2 Subtype/classification , Influenza A Virus, H3N2 Subtype/isolation & purification , North Carolina/epidemiology , Orthomyxoviridae Infections/transmission , Orthomyxoviridae Infections/virology , Phylogeny , Republic of Korea/epidemiology
10.
Genome Announc ; 5(23)2017 Jun 08.
Article in English | MEDLINE | ID: mdl-28596397

ABSTRACT

In December 2016, influenza A (H7N2) was first detected among cats in the New York City shelter system with subsequent widespread transmission. The sequence of the first clinical isolate, A/feline/New York/16-040082-1/2016(H7N2), and its genetic similarity to the live bird market lineage of H7N2 low-pathogenicity avian influenza are described.

11.
J Am Vet Med Assoc ; 248(9): 1022-6, 2016 May 01.
Article in English | MEDLINE | ID: mdl-27074610

ABSTRACT

OBJECTIVE To estimate an appropriate isolation period for dogs infected with canine influenza A H3N2 virus on the basis of the duration of virus shedding. DESIGN Retrospective case series. ANIMALS 16 dogs, from 3 Chicago area shelters, naturally infected with canine influenza A H3N2 virus. PROCEDURES Medical records of 16 affected dogs were reviewed. Nasal swab specimens from each dog had been tested periodically for a minimum of 15 days following an initial positive real-time reverse transcriptase PCR (rRT-PCR) assay result for influenza A virus shedding. Amplicons were purified, quantified, and sequenced by the Sanger DNA sequencing technique. Virus isolation and sequence results of canine influenza A H3N2 virus from nasal swab specimens were obtained in conjunction with signalment, description of clinical signs, type of treatment, and outcome. RESULTS Viruses from each dog were identified as canine influenza A H3N2 virus on the basis of DNA sequencing. The interval between first and last positive rRT-PCR assay results ranged from 13 to 24 days, whereas the time interval from first reported clinical signs to last positive assay results ranged from 15 to 26 days. Isolation of canine influenza A H3N2 virus was successful in the late shedding period from nasal swab specimens of 4 dogs at 15 and 20 days after the first positive rRT-PCR assay result and 18 to 20 days after the first clinical signs. Clinical signs resolved for all dogs that remained in the shelters during the testing period. CONCLUSIONS AND CLINICAL RELEVANCE Dogs infected with H3N2 virus should be isolated for a period of ≥ 21 days following onset of illness. Even when resolution of clinical signs occurs sooner than 21 days, shedding of H3N2 virus may persist.


Subject(s)
Disease Outbreaks/veterinary , Dog Diseases/virology , Influenza A Virus, H3N2 Subtype , Orthomyxoviridae Infections/veterinary , Virus Shedding , Age Distribution , Animals , Breeding , Chicago/epidemiology , Dog Diseases/epidemiology , Dogs , Female , Influenza A Virus, H3N2 Subtype/isolation & purification , Male , Multiplex Polymerase Chain Reaction/veterinary , Nasal Mucosa/virology , Orthomyxoviridae Infections/epidemiology , Orthomyxoviridae Infections/virology , Real-Time Polymerase Chain Reaction/veterinary , Sex Distribution
12.
J Feline Med Surg ; 17(4): 342-7, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25074567

ABSTRACT

Endemic Microsporum canis dermatophytosis was identified in a large, open admission, private, no-kill shelter that admitted >1200 cats per year. Fungal culture (FC) screening revealed that 166/210 (79%) and 38/99 (38%) cats in the non-public and public area were culture positive, respectively. However, pending screening FC results, the 99 cats in the public area were treated with once-weekly lime sulfur rinses and monitored with once-weekly FC. Cats in the non-public area were not treated. When FC results were available, cats were separated into low-risk (n = 61) and high-risk (n = 38) groups based upon the presence or absence of skin lesions. Low-risk cats continued to receive once-weekly topical lime sulfur and rapidly achieved culture-negative status. High-risk cats were divided into two groups based upon the number of colony-forming units/plate (low or high). All 38 cats were treated with twice-weekly lime sulfur and oral terbinafine and within 6-7 weeks only 5/38 cats were still FC-positive. These cats were moved to a separate room. Dermatophytosis was eradicated within 5 months; eradication was prolonged owing to reintroduction of disease into the remaining room of cats under treatment from three kittens returning from foster care. Continued admissions and adoptions were possible by the institution of intake procedures that specifically included careful Wood's lamp examination to identify high-risk cats and use of a 'clean break strategy'.


Subject(s)
Antifungal Agents/therapeutic use , Cat Diseases/drug therapy , Dermatomycoses/drug therapy , Dermatomycoses/veterinary , Housing, Animal , Animals , Calcium Compounds/therapeutic use , Cat Diseases/microbiology , Cat Diseases/pathology , Cats , Dermatomycoses/microbiology , Disease Management , Drug Therapy, Combination , Microsporum/isolation & purification , Sulfides/therapeutic use , Tinea/drug therapy , Treatment Outcome
13.
PLoS One ; 9(5): e96254, 2014.
Article in English | MEDLINE | ID: mdl-24825357

ABSTRACT

For animals in confinement housing the housing structure has tremendous potential to impact well being. Dogs in animal shelters are often housed in one of two types of confinement housing - single kennels and rooms or double compartment kennels and rooms most often separated by a guillotine door. This study examines the effect of housing on the location of elimination behavior in dogs housed in double compartment kennels were the majority of the dogs were walked daily. One side of the kennel contained the food, water and bed and the other side was empty and available except during cleaning time. Location of urination and defecation was observed daily for 579 dogs housed in indoor double compartment kennels for a total of 4440 days of observation. There were 1856 days (41.9%) when no elimination was noted in the kennel. Feces, urine or both were observed in the kennel on 2584 days (58.1%). When elimination occurred in the kennel the probability of fecal elimination on the opposite side of the bed/food/water was 72.5% (95% CI 69.05% to 75.69%). The probability of urination on the opposite side of the bed/food/water was 77.4% (95% CI 74.33% to 80.07%). This study demonstrates the strong preference of dogs to eliminate away from the area where they eat, drink and sleep. Double compartment housing not only allows this - it allows staff the ability to provide safe, efficient, humane daily care and confers the added benefits of reducing risks for disease transmission for the individual dog as well as the population.


Subject(s)
Behavior, Animal/physiology , Defecation/physiology , Housing, Animal , Urination/physiology , Animals , Dogs
14.
J Feline Med Surg ; 16(5): 407-18, 2014 May.
Article in English | MEDLINE | ID: mdl-24794037

ABSTRACT

PRACTICAL RELEVANCE: Dermatophytosis (ringworm) is the most important infectious and contagious skin disease of cats in shelters. Its importance relates to the fact that it can affect all cats, but tends to affect those which would otherwise have good chances for adoption. Although many diseases in shelters fit this description, dermatophytosis is of particular significance because of associated public health concerns. CLINICAL CHALLENGES: Disease management in animal shelters is challenging because new animals are frequently entering the population, numerous animals are often housed together, and resources are almost always limited. GLOBAL RELEVANCE: Outbreaks of dermatophytosis occur worldwide and no animal shelter is completely shielded from possible introduction of the disease into the population. AUDIENCE: This article offers a flexible stepwise approach to dealing with a known or suspected outbreak of dermatophytosis in an animal shelter. It is based on the authors' experiences spanning more than a decade of responses and/or consultations. While primarily aimed at veterinarians involved in shelter medicine, the principles largely apply to other group-housing situations, such as catteries and breeding establishments. AIMS: The goals in dealing with a potential dermatophytosis outbreak are to ascertain if the 'outbreak' is actually an outbreak, to develop a shelter-specific outbreak management plan and to implement a long-term plan to prevent recurrences.


Subject(s)
Cat Diseases/prevention & control , Dermatomycoses/veterinary , Disease Outbreaks/veterinary , Housing, Animal , Tinea/veterinary , Animal Husbandry , Animal Welfare/organization & administration , Animals , Antifungal Agents/administration & dosage , Cats , Dermatomycoses/prevention & control , Disease Outbreaks/prevention & control , Disinfection/methods , Infection Control/methods , Tinea/prevention & control , Veterinary Medicine
15.
Vet Dermatol ; 24(6): 618-20, e149-50, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24033387

ABSTRACT

BACKGROUND: Dermatophytosis is an important contagious and infectious skin disease in an animal shelter. Itraconazole is the commonly used systemic antifungal drug, but it is expensive in some countries and, at times, difficult to obtain. Terbinafine is a fungicidal allylamine with documented in vitro and in vivo efficacy against Microsporum canis in pet cats and in cats with experimental infections. HYPOTHESIS/OBJECTIVES: To describe the use of oral terbinafine for the treatment of M. canis dermatophytosis in shelter cats. METHODS: The response to treatment of 85 shelter cats with naturally occurring M. canis dermatophytosis was monitored by examination, weekly toothbrush fungal cultures and the number of colony-forming units on fungal culture plates. Cats were treated with either 14 (n = 21) or 21 days (n = 64) of terbinafine per os (p.o.) along with concurrent twice weekly lime sulphur rinses and daily environmental disinfection. RESULTS: Cats treated with 14 days of terbinafine p.o. showed an initial response to therapy but by week 6 had relapsed and required rescue therapy with a course of itraconazole (10 mg/kg p.o.) to obtain a cure. Cats treated with 21 days of terbinafine p.o. showed a response to treatment similar to published reports using itraconazole p.o. for 21 days. The mean and median number of days to mycological cure was 22.70 (range 13-39). Terbinafine was well tolerated. None of the cats developed oral lesions postgrooming of lime sulphur rinses. CLINICAL SIGNIFICANCE: Where itraconazole is not available, substitution with terbinafine in established protocols may allow shelters to treat cats that otherwise would go untreated.


Subject(s)
Antifungal Agents/therapeutic use , Calcium Compounds/therapeutic use , Cat Diseases/drug therapy , Dermatomycoses/veterinary , Naphthalenes/therapeutic use , Sulfides/therapeutic use , Animals , Antifungal Agents/administration & dosage , Cat Diseases/microbiology , Cats , Dermatomycoses/drug therapy , Dermatomycoses/microbiology , Drug Administration Schedule , Microsporum/drug effects , Naphthalenes/administration & dosage , Terbinafine
16.
Vet Dermatol ; 24(4): 460-2, e106, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23627423

ABSTRACT

BACKGROUND: Feline demodicosis is caused by infestation with Demodex cati and/or Demodex gatoi. These two mites have distinctive morphological appearances. OBJECTIVES: To describe five observations of a morphologically distinct feline Demodex mite in 10 cats. All cats were in or adopted from an animal shelter. RESULTS: A mite with blunted ends longer than D. gatoi but shorter than D. cati was observed in one or multiple cats from animal shelters. Mean mite size was 139 ± 4.5 µm (n = 41 mites). Similar features among the cases included a history of recent recovery or presence of concurrent illness at the time of diagnosis. Pruritus was variable. Hairs were easily epilated in large amounts, and mites were found on either skin scrapings or hair trichograms; mites were most commonly found on the proximal third of hairs examined via trichogram. CLINICAL IMPORTANCE: Reports of this mite are uncommon but when present tend to be in cats with concurrent illnesses. Awareness of this mite morphology will hopefully provide other investigators with specimens for molecular testing to determine whether this is a third species or a variant of D. gatoi or D. cati.


Subject(s)
Cat Diseases/parasitology , Mite Infestations/veterinary , Mites/classification , Animals , Cats , Mite Infestations/parasitology
17.
Vet Dermatol ; 22(1): 75-9, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20604908

ABSTRACT

In an open non-randomized study, 90 cats with severe dermatophytosis were treated with 21 days of oral itraconazole at 10 mg/kg and one of three topical antifungal rinses applied twice weekly: lime sulphur (LSO); reformulated lime sulphur with an odour-masking agent (LSR); or a 0.2% miconazole nitrate and 0.2% chlorhexidine gluconate rinse (MC). Weekly examinations and fungal cultures were used to monitor the cats' response to therapy. If at day 42 of treatment cats were still strongly fungal culture positive and/or developing new lesions, they were retreated with oral itraconazole and LSO. Cats were not prevented from licking the solutions and none developed oral ulcerations. Thirty-one cats were treated with LSO, 27 with LSR and 32 with MC. The median number of days to cure was 30 (range 10-69 days) and 34 (range 23-80 days) for LSO and LSR, respectively. Thirty-two cats were treated with MC, and 13 of 32 cats required repeat treatment because of persistent culture-positive status and development of new lesions. Median number of days of treatment for the 19 cats that cured with MC was 48 (range 14-93 days). When the number of days to cure was compared between the groups, there was a significant difference between cats treated with LSO and LSR (P=0.029) and cats treated with LSO and MC (P=0.031), but no significant difference between the number of days to cure for cats treated with LSR and MC (P=0.91).


Subject(s)
Antifungal Agents/therapeutic use , Cat Diseases/drug therapy , Dermatomycoses/veterinary , Animals , Antifungal Agents/administration & dosage , Calcium Compounds/administration & dosage , Calcium Compounds/therapeutic use , Cats , Chlorhexidine/administration & dosage , Chlorhexidine/therapeutic use , Dermatomycoses/drug therapy , Drug Administration Schedule , Drug Therapy, Combination , Housing, Animal , Itraconazole/administration & dosage , Itraconazole/therapeutic use , Miconazole/administration & dosage , Miconazole/therapeutic use , Microsporum , Sulfides/administration & dosage , Sulfides/therapeutic use , Thiosulfates/administration & dosage , Thiosulfates/therapeutic use
18.
J Am Vet Med Assoc ; 233(1): 74-86, 2008 Jul 01.
Article in English | MEDLINE | ID: mdl-18593314

ABSTRACT

As efforts to reduce the overpopulation and euthanasia of unwanted and unowned dogs and cats have increased, greater attention has been focused on spay-neuter programs throughout the United States. Because of the wide range of geographic and demographic needs, a wide variety of programs have been developed to increase delivery of spay-neuter services to targeted populations of animals, including stationary and mobile clinics, MASH-style operations, shelter services, feral cat programs, and services provided through private practitioners. In an effort to ensure a consistent level of care, the Association of Shelter Veterinarians convened a task force of veterinarians to develop veterinary medical care guidelines for spay-neuter programs. The guidelines consist of recommendations for preoperative care (eg, patient transport and housing, patient selection, client communication, record keeping, and medical considerations), anesthetic management (eg, equipment, monitoring, perioperative considerations, anesthetic protocols, and emergency preparedness), surgical care (eg, operating-area environment; surgical-pack preparation; patient preparation; surgeon preparation; surgical procedures for pediatric, juvenile, and adult patients; and identification of neutered animals), and postoperative care (eg, analgesia, recovery, and release). These guidelines are based on current principles of anesthesiology, critical care medicine, microbiology, and surgical practice, as determined from published evidence and expert opinion. They represent acceptable practices that are attainable in spay-neuter programs.


Subject(s)
Anesthesia/veterinary , Castration/veterinary , Cats/surgery , Dogs/surgery , Population Control , Veterinary Medicine/standards , Anesthesia/standards , Animals , Castration/methods , Castration/standards , Euthanasia, Animal , Female , Male , Patient Selection , Postoperative Care/standards , Postoperative Care/veterinary , Societies , United States
19.
Vet Dermatol ; 18(5): 324-31, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17845620

ABSTRACT

Dermatophytosis is the most common contagious and infectious skin disease of cats. It is of particular importance in animal shelters because it is a known zoonosis, highly contagious, and easily transmitted. In this open clinical trial, 58 cats with confirmed Microsporum canis dermatophytosis and 32 uninfected bonded pairs or littermates were treated with a combination of 21 days of oral itraconazole (10 mg kg(-1)) and twice weekly lime sulphur rinses until cured. Cats were not clipped in this treatment programme. Fungal cultures were obtained once weekly on all cats, and cats were considered cured when they had two consecutive negative weekly fungal cultures. Cats were held in the facility and received continued topical treatment until the fungal cultures were finalized. None of the cats developed oral ulcerations as a result of grooming the lime sulphur rinses. Oral ulcerations only developed in cats with clinical signs associated with upper respiratory disease. None of the uninfected cats living in contact with infected cats became culture positive or developed skin lesions. When data were examined retrospectively and the number of days to finalize the cultures was subtracted (21 days) from the total number of days the cats were housed in the annex, the mean number of days of treatment required for cure was 18.4 +/- 9.5 SEM (range 10-49 days). Cats with more severe infections required longer therapy. In this shelter, the combination of oral itraconazole and topical lime sulphur rinses for the treatment of dermatophytosis was effective and safe.


Subject(s)
Antifungal Agents/therapeutic use , Calcium Compounds/therapeutic use , Cat Diseases/drug therapy , Dermatomycoses/veterinary , Itraconazole/therapeutic use , Microsporum , Sulfides/therapeutic use , Thiosulfates/therapeutic use , Administration, Oral , Animals , Antifungal Agents/administration & dosage , Baths , Calcium Compounds/administration & dosage , Cat Diseases/pathology , Cats , Dermatomycoses/drug therapy , Drug Therapy, Combination , Female , Housing, Animal , Itraconazole/administration & dosage , Male , Sulfides/administration & dosage , Thiosulfates/administration & dosage , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...